DE3319177A1 - Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external use - Google Patents
Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external useInfo
- Publication number
- DE3319177A1 DE3319177A1 DE19833319177 DE3319177A DE3319177A1 DE 3319177 A1 DE3319177 A1 DE 3319177A1 DE 19833319177 DE19833319177 DE 19833319177 DE 3319177 A DE3319177 A DE 3319177A DE 3319177 A1 DE3319177 A1 DE 3319177A1
- Authority
- DE
- Germany
- Prior art keywords
- contain
- bases according
- bases
- disinfectants
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Propionsäure-Ethyl- bezw.-IsopropylesterEthyl propionate or isopropyl ester
enthaltende Gflrndlagen fijr äußerlich anzuwendende Arznei- und Desinfektionsmittel Zur verbesserung der percutanen Aufnahme von Arzneimitteln sind bereits verschiedene organische Flüssigkeiten vorgeschlagen worden bezw. im gebrauch. Zu den älteren gehören niedere einbis dreiwertige Alkohole und Öle verschiedenster Provenienz, zu den neueren beispielsweise Cyclohexan und Dimetharlsulfoxid.Containing base layers for external medicinal products and disinfectants To improve the percutaneous absorption of drugs, there are already various organic liquids have been proposed respectively. in use. To the older ones include lower mono- to trihydric alcohols and oils of various origins, the newer ones, for example, cyclohexane and dimetharl sulfoxide.
Die Anforderungen an diese Stoffe sind im wesentlichen folgende: Physiologische Unbedenklichkeit, ein gewisses Lösevermögen für das betreffende Arzneimittel, gute Penetration, Es wurde gefunden, daJ! Propionsäure-Ethvl und Isopropylester für bestimmte Anwendungsfälle itnd Arzneimittel diese Anforderungen besonders gut erfüllen. Ihr Siedepunkt liegt bei 99 bezw. 110°C, ihr Lösevermögen ist dem von Essigsäure-Ethylester ähnlich, vor allem ist ihre Penetration wegen des ausgeglichen hydrophob/hydrophylen Charakters sehr gut.Dieser kann durch Verwenden von Gemischen der beiden Ester auf die jeweiligen Erfordernisse abgestimmt werden.The requirements for these substances are essentially as follows: Physiological Harmlessness, a certain dissolving power for the drug in question, good Penetration, it was found that! Ethvl propionate and isopropyl ester for certain Applications with pharmaceuticals meet these requirements particularly well. you Boiling point is 99 respectively. 110 ° C, its dissolving power is that of ethyl acetate similar, especially their penetration is due to the balanced hydrophobic / hydrophilic Character very good. This can be achieved by using mixtures of the two esters the respective requirements are coordinated.
Zusätzlich kann für verschiedene Anwendungsfälle ihre vergleichsweise hohe Flüchtigkeit dazu ausgenutzt werden, fliichtige Arzneimittel an schwer zugängige Erkrankungsherde zu transportieren.In addition, their comparative can be used for different applications high volatility to be exploited, volatile drugs to difficult to access To transport foci of disease.
Schließlich weisen die Propionsäure-Ester als solche bereits gewisse antimycotische Wirkungen auf, so daß ihre Anwendung in Antimycotica besonders sinnvoll ist.Finally, the propionic acid esters as such already have certain antimycotic effects, so that their use in antimycotics is particularly useful is.
Nach dem vorhergehenden kommen die genannten Ester enthaltende Grundlagen besonders für folgende Gruppen von Arzneimitteln inbetracht: Antimycotica, Dermatica, Antiphlogistica, Analgetica, Antirheumatica, Venenmittel.After the foregoing come the esters-containing bases mentioned Particularly considered for the following groups of medicinal products: Antimycotica, Dermatica, Antiphlogistics, analgesics, antirheumatics, venous drugs.
Ihre Eigenschaften prädestinieren die Ester auch für die Anwendung in Desinfektionsmitteln. Bei diesen sowie besonders auch bei solchen Antimycotica, welche für die Behandlung von Onychomycosen vorgesehen sind, kann es von Vorteil sein, den gemeinsamen Transport von Träger und Wirdstoff zu schwer zugängigen Bezirken im Gaszustand zu bewirken.The properties of the esters also make them ideal for use in disinfectants. With these and especially with those antimycotics, which are intended for the treatment of onychomycoses, it can be beneficial be the joint transport of porters and materials to areas that are difficult to access to effect in the gas state.
Die Grundlagen gemäß vorliegender Erfindung können die Propionsäure-Ester konzentriert (beispielsweise zur Warzenbehandlung), mit gebräuchlichen Lösungsmiitteln verdünnt, gemeinsam mit olen und Fetten, mit Wasser und Läsungsmitteln verdünnt, gemeinsam mit Wasser und Surfactants enthalten.The bases according to the present invention can be the propionic acid esters concentrated (e.g. for wart treatment), with common solvents diluted, together with oils and fats, diluted with water and solvents, included together with water and surfactants.
Ihre Konsistenz kann mit Hilfe von organiscijen oder anorganischen Hilfsstoffen nach Belieben von flüssig bis halbfest eingestellt werden.Their consistency can be organic or inorganic Auxiliaries can be adjusted from liquid to semi-solid as desired.
Beispiele Beispiel 1) Zur Behandlung einer Onychomycose wurde ein Präparat folgender Zusammensetzung angewandt: Propionsäure-Ethylester 35 Thymol 20 Dichlorophen 3 Cetylpyridiniumbromid 2 Isopropylalkohol 30 Wasser ad 100 beispiel 2) In der Rezeptur des Beispiels 1) wurde der Ethyl- durch den Isopropyl-Ester ersetzt. Examples Example 1) For the treatment of an onychomycosis, a Preparation of the following composition used: Ethyl propionate 35 thymol 20 dichlorophene 3 cetylpyridinium bromide 2 isopropyl alcohol 30 water ad 100 example 2) In the recipe of example 1) the ethyl ester was replaced by the isopropyl ester.
Beispiel 3j Zur Behandlung einer Onychomycose mit "Taschenbildung" und bereits weitgehend zerstörter Nagelsubstanz wurde ein Präparat folgender Zusammensetzung angewandt: Propionsäure-Ethylester 30,0 " Isopropylester 30,0 Walnußol 30,0 Vitamin E 0,5 Thymol 5,0 Cetylpyridiniumbromid 1,0 Salicylsäure 1,0 Wasser ad 100 Die Abheilung der Mycose gelang auch in den "Taschen" der Nägel, welche der Pilz gebildet hatte, mittels der kombinierten Diffusion der Ester und des Thymols im Gaszustand.Example 3j for the treatment of an onychomycosis with "pocket formation" and nail substance already largely destroyed was a preparation of the following composition applied: ethyl propionate 30.0 "isopropyl ester 30.0 walnut oil 30.0 vitamin E 0.5 thymol 5.0 cetylpyridinium bromide 1.0 salicylic acid 1.0 water ad 100 The healing the mycosis also succeeded in the "pockets" of the nails which the fungus had formed, by means of the combined diffusion of the esters and thymol in the gas state.
Beispiel 4) Zur Händesinfektion wurde ein Präparat folgender Zusammensetzung angewandt: Propionsäure-Ethylester 10,0 Thymol 1,0 Benzalkonimchlorid 0,05 Isopropanol 55 wasser ad 100Example 4) A preparation of the following composition was used for hand disinfection used: ethyl propionate 10.0 thymol 1.0 benzalkonim chloride 0.05 isopropanol 55 water ad 100
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833319177 DE3319177A1 (en) | 1983-05-26 | 1983-05-26 | Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833319177 DE3319177A1 (en) | 1983-05-26 | 1983-05-26 | Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3319177A1 true DE3319177A1 (en) | 1984-11-29 |
Family
ID=6199965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19833319177 Withdrawn DE3319177A1 (en) | 1983-05-26 | 1983-05-26 | Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external use |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE3319177A1 (en) |
-
1983
- 1983-05-26 DE DE19833319177 patent/DE3319177A1/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69733086T2 (en) | PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN KUUU NUTS OIL | |
EP1818041B1 (en) | Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid | |
DE60202946T2 (en) | FUNGICIDES CONTAINING TOPICAL COMPOSITION | |
DE69729932T2 (en) | Compositions for increasing the skin penetration of drugs using permeation enhancers | |
DE2418345C2 (en) | Pharmaceutical agent for external use on human skin | |
EP1819317B1 (en) | Medicament and system for the percutaneous administration of medicaments | |
DE10361022A1 (en) | Topical preparations containing dimethyl sulfoxide and dexpanthenol | |
DE3872521T2 (en) | LIQUID CONTAINING STEROIDS. | |
DE3032462A1 (en) | PREPARATIONS FOR USE ON OR IN TISSUE AND / OR LIQUIDS OF THE HUMAN OR ANIMAL BODY | |
EP0582239A1 (en) | Pharmaceutical and/or cosmetic preparation and the use of such a preparation | |
DE69027220T2 (en) | COMPOSITION AND METHOD FOR TREATING PAINFUL INFLAMMABLE OR ALLERGIC DISEASES | |
DE68907335T2 (en) | Microgranules loaded with an active ingredient consisting essentially of triglycerides of saturated fatty acids and their external therapeutic use. | |
DE2601489C2 (en) | ||
DE69022314T2 (en) | Stable emulsified tretinoin cream formulations. | |
EP0584126B1 (en) | Penetration-promoting substance | |
EP3666259A1 (en) | Foamable aqueous compositions based on biopolymeres having use-flexible gas storage cell distribution | |
KR970032872A (en) | Drugs for the treatment of skin damage containing acetylsalicylic acid | |
DE2164052A1 (en) | COSMETIC AGENTS WITH NUCLEOSIDE DERIVATIVES | |
EP1885328B1 (en) | Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine | |
DE2316597A1 (en) | DERMATOLOGICAL PREPARATION | |
DE69122229T2 (en) | PENCICLOVIR CONTAINING PHARMACEUTICAL FORMULATION | |
DE3319177A1 (en) | Bases containing ethyl and/or isopropyl propionate for medicaments and disinfectants for external use | |
DE202020104615U1 (en) | Disinfectant, skin-friendly, nourishing and moisturizing agent for application to the skin | |
DE68906775T2 (en) | Protect, nourish and treat the skin. | |
DE2226927A1 (en) | COMPOSITION AND ADMINISTRATION FORM EFFECTIVE AGAINST ADDICTION AND CELLULITIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8127 | New person/name/address of the applicant |
Owner name: SCHOBER, ROLF, DIPL.-CHEM.DR., 7801 UMKIRCH, DE |
|
8139 | Disposal/non-payment of the annual fee |